Biomerica, Inc.
BMRA
$2.38
-$0.02-0.63%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.32M | 2.00K | -1.54M | -1.16M | -950.00K |
| Total Depreciation and Amortization | 103.00K | 102.00K | 104.00K | 99.00K | 100.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 105.00K | 178.00K | 158.00K | 72.00K | 148.00K |
| Change in Net Operating Assets | 121.00K | -550.00K | 621.00K | -53.00K | -89.00K |
| Cash from Operations | -991.00K | -268.00K | -661.00K | -1.05M | -791.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | -4.00K | -33.00K |
| Cash from Investing | -- | -- | 0.00 | -4.00K | -33.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 493.00K | 939.00K | -- | 1.77M | 392.00K |
| Repurchase of Common Stock | -- | -- | -1.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11.00K | -19.00K | -4.00K | -31.00K | -12.00K |
| Cash from Financing | 482.00K | 920.00K | -5.00K | 1.74M | 380.00K |
| Foreign Exchange rate Adjustments | -1.00K | 2.00K | 8.00K | -1.00K | -4.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -510.00K | 654.00K | -658.00K | 686.00K | -448.00K |